My work is embedded in a broad network of national and international collaborations across psychiatry, psychiatric genetics, neuropsychopharmacology, computational psychiatry, and translational neuroscience.
I collaborate with research groups and consortia in Italy, the Netherlands, Germany, Austria, Spain, Denmark, Norway, the United Kingdom, and other countries, with a shared focus on psychiatric genomics, pharmacogenomics, treatment outcomes, suicide research, and psychiatric–metabolic multimorbidity.
I have contributed to several European and international research initiatives, including Horizon 2020 PRIME, IMI2 JU PRISM and PRISM2, Horizon Europe Psych-STRATA, and the PNRR MNESYS programme. These collaborations involve large-scale genomic, imaging-genetic, multi-omic, clinical, and epidemiological analyses aimed at improving stratification, prediction, and treatment development in psychiatry.
I am also active in scientific societies and networks that connect clinical psychiatry, biological psychiatry, and psychiatric genetics. These include the European College of Neuropsychopharmacology, the ECNP Network on Suicide Research and Prevention, the Psychiatric Genomics Consortium Suicide Working Group, the International Society of Psychiatric Genetics, the Collegium Internationale Neuro-Psychopharmacologicum, the Hierarchical Taxonomy of Psychopathology Society, and COMP-PSY, the Italian Network for Computational Psychiatry.
Selected areas of collaboration include:
International psychiatric genomics consortia
European projects on psychiatric–metabolic multimorbidity
Suicide research and prevention networks
Pharmacogenomics and treatment outcome studies
Computational psychiatry
Clinical and translational research in mood and psychotic disorders
Multi-omic and imaging-genetic studies
Drug repurposing and therapeutic target prioritisation in psychiatry
Meta-analyses